title: [New drugs for small animals in 2010].
abstract: In 2010, no active pharmaceutical ingredients were released on the German market for small animals. Furthermore, no additional substances were authorized for additional species. Only one drug with an interesting new pharmaceutical form, two products with a new strength and one drug, which is interesting because of other criteria, were added to the market for small animals. In addition, nine active pharmaceutical ingredients with approval for use in human medicine, which are of potential interest for veterinary medicine, entered the market in 2010. Those are the analgesic Tapentadol, the antiallergicum Bilastine, the antiarrhythmics Dronedarone and Vernakalant, the antihaemorrhagic Eltrombopag, the bronchodilator Roflumilast, the hormone Corifollitropin alfa, the laxative Prucalopride and the cytostatic Mifamurtide.
authors.affiliation: Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät der Universität Leipzig, An den Tierkliniken 15, Leipzig. emmerich@vetmed.uni-leipzig.de
authors.forename: I U
authors.initials: IU
authors.lastname: Emmerich
mesh_terms: D000818:Animals; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005858:Germany; D006801:Humans; D019155:Veterinary Drugs / Q000737:chemistry / Q000592:standards / Q000627:therapeutic use*
chemical_list: D019155:Veterinary Drugs